Asset Managers

Downstream investors can target gains that are on par with those produced by leading biomedical funds through high-quality, portfolio-ready investment opportunities that might otherwise be overlooked and cost-prohibitive because of their mid-continent origin.

Mid-Continent University Innovators

Just like their best peers on either coast, mid-continent innovators can co-found successful scientific startups contribute to society’s greater good and create economic value, in addition to enhancing the resources of their labs and the opportunities for their colleagues.

CEOs and Other Scaling Business Talent

C-suite executives who have successfully scaled startups can bring their talents to bear to increase human health and wellbeing, by accessing extraordinary opportunities to build and create economic value – opportunities that may well be overlooked or not considered because of their mid-continent origin.

Philanthropists

Individuals, family offices and philanthropic foundations can enhance the economic and societal impact of their philanthropic investments in a research university – including cures for life-threatening diseases – while attracting additional investments from other donors. They, too, can identify and invest in preeminent innovators capable of solving societal problems that are a priority to them.